Ophthalmology Management
@ophthalmologymg.bsky.social
Payment cuts, parity decisions, and new compliance rules are coming for ophthalmic ASCs.
At #AAO2025, Mike Romansky, JD, broke down what centers need to prepare for — including a 4.7% cataract rate drop and new PA requirements.
Full recap:
https://ow.ly/N3eV50Xuy17
#Ophthalmology
At #AAO2025, Mike Romansky, JD, broke down what centers need to prepare for — including a 4.7% cataract rate drop and new PA requirements.
Full recap:
https://ow.ly/N3eV50Xuy17
#Ophthalmology
November 26, 2025 at 3:50 PM
Payment cuts, parity decisions, and new compliance rules are coming for ophthalmic ASCs.
At #AAO2025, Mike Romansky, JD, broke down what centers need to prepare for — including a 4.7% cataract rate drop and new PA requirements.
Full recap:
https://ow.ly/N3eV50Xuy17
#Ophthalmology
At #AAO2025, Mike Romansky, JD, broke down what centers need to prepare for — including a 4.7% cataract rate drop and new PA requirements.
Full recap:
https://ow.ly/N3eV50Xuy17
#Ophthalmology
CMS has delayed the ASC prior authorization program to early 2026, following advocacy from OOSS, AAO & others.
The PA rollout—affecting blepharoplasty, ptosis repair, brow lifts & Botox in 10 states—was set for Dec 15.
Read more → https://ow.ly/GYL250XwKEK
#Ophthalmology #ASC
The PA rollout—affecting blepharoplasty, ptosis repair, brow lifts & Botox in 10 states—was set for Dec 15.
Read more → https://ow.ly/GYL250XwKEK
#Ophthalmology #ASC
November 25, 2025 at 1:30 PM
CMS has delayed the ASC prior authorization program to early 2026, following advocacy from OOSS, AAO & others.
The PA rollout—affecting blepharoplasty, ptosis repair, brow lifts & Botox in 10 states—was set for Dec 15.
Read more → https://ow.ly/GYL250XwKEK
#Ophthalmology #ASC
The PA rollout—affecting blepharoplasty, ptosis repair, brow lifts & Botox in 10 states—was set for Dec 15.
Read more → https://ow.ly/GYL250XwKEK
#Ophthalmology #ASC
📢 Sydnexis has announced that the FDA has issued a Complete Response Letter for its NDA for SYD-101, a proprietary 0.01% atropine formulation intended to slow myopia progression in children.
Full article: https://ow.ly/W3A850XwTK0
#Ophthalmology #OphthalmologyNews #MyopiaControl
Full article: https://ow.ly/W3A850XwTK0
#Ophthalmology #OphthalmologyNews #MyopiaControl
November 24, 2025 at 3:25 PM
📢 Sydnexis has announced that the FDA has issued a Complete Response Letter for its NDA for SYD-101, a proprietary 0.01% atropine formulation intended to slow myopia progression in children.
Full article: https://ow.ly/W3A850XwTK0
#Ophthalmology #OphthalmologyNews #MyopiaControl
Full article: https://ow.ly/W3A850XwTK0
#Ophthalmology #OphthalmologyNews #MyopiaControl
📉✨ New long-term GA data is in.
Apellis reports that 5 years of continuous Syfovre treatment slowed lesion growth by ~1.5 years vs projected sham — with consistent safety through year 5.
Full story: https://ow.ly/ZOpo50Xuz76
#Ophthalmology #Retina #GA #AMD #ClinicalTrials
Apellis reports that 5 years of continuous Syfovre treatment slowed lesion growth by ~1.5 years vs projected sham — with consistent safety through year 5.
Full story: https://ow.ly/ZOpo50Xuz76
#Ophthalmology #Retina #GA #AMD #ClinicalTrials
November 24, 2025 at 2:25 PM
📉✨ New long-term GA data is in.
Apellis reports that 5 years of continuous Syfovre treatment slowed lesion growth by ~1.5 years vs projected sham — with consistent safety through year 5.
Full story: https://ow.ly/ZOpo50Xuz76
#Ophthalmology #Retina #GA #AMD #ClinicalTrials
Apellis reports that 5 years of continuous Syfovre treatment slowed lesion growth by ~1.5 years vs projected sham — with consistent safety through year 5.
Full story: https://ow.ly/ZOpo50Xuz76
#Ophthalmology #Retina #GA #AMD #ClinicalTrials
A world first: Precise Bio has implanted the first 3D-bio-printed corneal implant (PB-001) in a patient at Rambam Medical Center.
Built from living corneal cells, the implant aims to reduce donor dependence and restore sight.
Full story: https://ow.ly/b0sx50XuyRL
#Ophthalmology
Built from living corneal cells, the implant aims to reduce donor dependence and restore sight.
Full story: https://ow.ly/b0sx50XuyRL
#Ophthalmology
November 21, 2025 at 2:10 PM
A world first: Precise Bio has implanted the first 3D-bio-printed corneal implant (PB-001) in a patient at Rambam Medical Center.
Built from living corneal cells, the implant aims to reduce donor dependence and restore sight.
Full story: https://ow.ly/b0sx50XuyRL
#Ophthalmology
Built from living corneal cells, the implant aims to reduce donor dependence and restore sight.
Full story: https://ow.ly/b0sx50XuyRL
#Ophthalmology
At #AAO2025, ASC leaders shared practical ways to boost efficiency — from precision turnover and smarter tech integration to “all hands on deck” teamwork.
Full insights:
https://ow.ly/9uwx50XuxMF
#Ophthalmology #ASC #SurgeryCenters
Full insights:
https://ow.ly/9uwx50XuxMF
#Ophthalmology #ASC #SurgeryCenters
November 20, 2025 at 2:45 PM
At #AAO2025, ASC leaders shared practical ways to boost efficiency — from precision turnover and smarter tech integration to “all hands on deck” teamwork.
Full insights:
https://ow.ly/9uwx50XuxMF
#Ophthalmology #ASC #SurgeryCenters
Full insights:
https://ow.ly/9uwx50XuxMF
#Ophthalmology #ASC #SurgeryCenters
CAM in oculoplastics: less inflammation and scarring, better handling, and strong outcomes in eyelid and socket reconstruction. When to choose thicker grafts, how to set expectations, and where CAM beats traditional grafts.
Read: https://ow.ly/ELBG50XpVvp
#Ophthalmology
Read: https://ow.ly/ELBG50XpVvp
#Ophthalmology
November 19, 2025 at 2:25 PM
CAM in oculoplastics: less inflammation and scarring, better handling, and strong outcomes in eyelid and socket reconstruction. When to choose thicker grafts, how to set expectations, and where CAM beats traditional grafts.
Read: https://ow.ly/ELBG50XpVvp
#Ophthalmology
Read: https://ow.ly/ELBG50XpVvp
#Ophthalmology
Dry eye is entering a new phase. A Lumenis panel at VisionExpo West highlighted overlooked factors like lower lid laxity and the dominant role of MGD, along with the growing impact of IPL and advanced diagnostics.
Full story:
https://ow.ly/HBuc50XsWEg
#DryEye #MGD #Ophthalmology
Full story:
https://ow.ly/HBuc50XsWEg
#DryEye #MGD #Ophthalmology
November 18, 2025 at 4:20 PM
Dry eye is entering a new phase. A Lumenis panel at VisionExpo West highlighted overlooked factors like lower lid laxity and the dominant role of MGD, along with the growing impact of IPL and advanced diagnostics.
Full story:
https://ow.ly/HBuc50XsWEg
#DryEye #MGD #Ophthalmology
Full story:
https://ow.ly/HBuc50XsWEg
#DryEye #MGD #Ophthalmology
👁️ The Nov/Dec issue of Ophthalmology Management is here!
This issue looks ahead to the future of ophthalmic care — from innovation in presbyopia and pterygium treatments to evolving surgical techniques and smarter practice management.
📖 Explore the full digital edition: https://ow.ly/1Lin50XpVRc
This issue looks ahead to the future of ophthalmic care — from innovation in presbyopia and pterygium treatments to evolving surgical techniques and smarter practice management.
📖 Explore the full digital edition: https://ow.ly/1Lin50XpVRc
November 17, 2025 at 2:35 PM
👁️ The Nov/Dec issue of Ophthalmology Management is here!
This issue looks ahead to the future of ophthalmic care — from innovation in presbyopia and pterygium treatments to evolving surgical techniques and smarter practice management.
📖 Explore the full digital edition: https://ow.ly/1Lin50XpVRc
This issue looks ahead to the future of ophthalmic care — from innovation in presbyopia and pterygium treatments to evolving surgical techniques and smarter practice management.
📖 Explore the full digital edition: https://ow.ly/1Lin50XpVRc
👀 New research provides the first real-time look at how VR use affects tear film dynamics. A built-in micro-camera in a VR headset showed tear film changes and temperature increases during a 30-minute session.
👉 Read more: https://ow.ly/sqkI50XrbOq
#Ophthalmology #VR #EyeHealth
👉 Read more: https://ow.ly/sqkI50XrbOq
#Ophthalmology #VR #EyeHealth
November 14, 2025 at 5:10 PM
👀 New research provides the first real-time look at how VR use affects tear film dynamics. A built-in micro-camera in a VR headset showed tear film changes and temperature increases during a 30-minute session.
👉 Read more: https://ow.ly/sqkI50XrbOq
#Ophthalmology #VR #EyeHealth
👉 Read more: https://ow.ly/sqkI50XrbOq
#Ophthalmology #VR #EyeHealth
👁️ VR meets cataract care.
Dr. Zachary Zavodni shares how virtual reality patient education boosted confidence — and premium IOL conversions.
🔗 https://ow.ly/mPsm50XnT9Q
#Ophthalmology #VR #PatientCare
Dr. Zachary Zavodni shares how virtual reality patient education boosted confidence — and premium IOL conversions.
🔗 https://ow.ly/mPsm50XnT9Q
#Ophthalmology #VR #PatientCare
November 13, 2025 at 5:01 PM
👁️ VR meets cataract care.
Dr. Zachary Zavodni shares how virtual reality patient education boosted confidence — and premium IOL conversions.
🔗 https://ow.ly/mPsm50XnT9Q
#Ophthalmology #VR #PatientCare
Dr. Zachary Zavodni shares how virtual reality patient education boosted confidence — and premium IOL conversions.
🔗 https://ow.ly/mPsm50XnT9Q
#Ophthalmology #VR #PatientCare
Presbyopia drops are more than symptom relief. They can start a lifelong care pathway with flexible dosing, realistic expectations, and better follow-up.
FDA-approved: Qlosi, Vuity, Vizz.
Read in Ophthalmology Management 👉 https://ow.ly/IAC150XpSTI
#Ophthalmology
FDA-approved: Qlosi, Vuity, Vizz.
Read in Ophthalmology Management 👉 https://ow.ly/IAC150XpSTI
#Ophthalmology
November 12, 2025 at 2:40 PM
Presbyopia drops are more than symptom relief. They can start a lifelong care pathway with flexible dosing, realistic expectations, and better follow-up.
FDA-approved: Qlosi, Vuity, Vizz.
Read in Ophthalmology Management 👉 https://ow.ly/IAC150XpSTI
#Ophthalmology
FDA-approved: Qlosi, Vuity, Vizz.
Read in Ophthalmology Management 👉 https://ow.ly/IAC150XpSTI
#Ophthalmology
847 children. 36 months.
Sydnexis’ SYD-101 0.01% atropine slowed myopia progression and met all major endpoints in the phase 3 STAR trial.
Click here to read more 🔗 https://ow.ly/wF0Y50XnTqv
#PediatricMyopia #Ophthalmology
Sydnexis’ SYD-101 0.01% atropine slowed myopia progression and met all major endpoints in the phase 3 STAR trial.
Click here to read more 🔗 https://ow.ly/wF0Y50XnTqv
#PediatricMyopia #Ophthalmology
November 11, 2025 at 5:05 PM
847 children. 36 months.
Sydnexis’ SYD-101 0.01% atropine slowed myopia progression and met all major endpoints in the phase 3 STAR trial.
Click here to read more 🔗 https://ow.ly/wF0Y50XnTqv
#PediatricMyopia #Ophthalmology
Sydnexis’ SYD-101 0.01% atropine slowed myopia progression and met all major endpoints in the phase 3 STAR trial.
Click here to read more 🔗 https://ow.ly/wF0Y50XnTqv
#PediatricMyopia #Ophthalmology
👁️ Effective Treatment of Pterygium
Dr. Richard Najac shares how timing, patient care, and cryopreserved amniotic membranes can improve surgical outcomes and reduce recurrence.
🔗 https://ow.ly/hjnX50Xn0qG
#Ophthalmology #EyeCare #Surgery
Dr. Richard Najac shares how timing, patient care, and cryopreserved amniotic membranes can improve surgical outcomes and reduce recurrence.
🔗 https://ow.ly/hjnX50Xn0qG
#Ophthalmology #EyeCare #Surgery
November 10, 2025 at 2:10 PM
👁️ Effective Treatment of Pterygium
Dr. Richard Najac shares how timing, patient care, and cryopreserved amniotic membranes can improve surgical outcomes and reduce recurrence.
🔗 https://ow.ly/hjnX50Xn0qG
#Ophthalmology #EyeCare #Surgery
Dr. Richard Najac shares how timing, patient care, and cryopreserved amniotic membranes can improve surgical outcomes and reduce recurrence.
🔗 https://ow.ly/hjnX50Xn0qG
#Ophthalmology #EyeCare #Surgery
👁️ Everything you need to know in Ophthalmology — all in one place.
From breakthroughs to clinical updates, stay informed with Ophthalmology Management News.
📰 Read the latest: https://ow.ly/qWrV50X8lGg
#EyeCare #VisionResearch #MedicalNews #Ophthalmology
From breakthroughs to clinical updates, stay informed with Ophthalmology Management News.
📰 Read the latest: https://ow.ly/qWrV50X8lGg
#EyeCare #VisionResearch #MedicalNews #Ophthalmology
November 7, 2025 at 1:40 PM
👁️ Everything you need to know in Ophthalmology — all in one place.
From breakthroughs to clinical updates, stay informed with Ophthalmology Management News.
📰 Read the latest: https://ow.ly/qWrV50X8lGg
#EyeCare #VisionResearch #MedicalNews #Ophthalmology
From breakthroughs to clinical updates, stay informed with Ophthalmology Management News.
📰 Read the latest: https://ow.ly/qWrV50X8lGg
#EyeCare #VisionResearch #MedicalNews #Ophthalmology
🚨 FDA rejects Regeneron’s application for the Eylea HD prefilled syringe, citing manufacturing issues at a third-party site.
Regeneron plans to resubmit by Jan 2026.
🔗 https://ow.ly/rNCl50Xn0LG
#Ophthalmology #EyleaHD #FDA #PharmaNews
Regeneron plans to resubmit by Jan 2026.
🔗 https://ow.ly/rNCl50Xn0LG
#Ophthalmology #EyleaHD #FDA #PharmaNews
November 6, 2025 at 3:15 PM
🚨 FDA rejects Regeneron’s application for the Eylea HD prefilled syringe, citing manufacturing issues at a third-party site.
Regeneron plans to resubmit by Jan 2026.
🔗 https://ow.ly/rNCl50Xn0LG
#Ophthalmology #EyleaHD #FDA #PharmaNews
Regeneron plans to resubmit by Jan 2026.
🔗 https://ow.ly/rNCl50Xn0LG
#Ophthalmology #EyleaHD #FDA #PharmaNews
👁️ Eye on the Future
Ophthalmology Management marks the end of an era — and the start of a new one.
Chief Editor Lisa Feulner, MD, PhD, shares how the publication is evolving to meet the digital age.
🔗 https://ow.ly/4gOf50Xn0fE
#Ophthalmology #EyeCare #DigitalTransformation
Ophthalmology Management marks the end of an era — and the start of a new one.
Chief Editor Lisa Feulner, MD, PhD, shares how the publication is evolving to meet the digital age.
🔗 https://ow.ly/4gOf50Xn0fE
#Ophthalmology #EyeCare #DigitalTransformation
November 5, 2025 at 1:55 PM
👁️ Eye on the Future
Ophthalmology Management marks the end of an era — and the start of a new one.
Chief Editor Lisa Feulner, MD, PhD, shares how the publication is evolving to meet the digital age.
🔗 https://ow.ly/4gOf50Xn0fE
#Ophthalmology #EyeCare #DigitalTransformation
Ophthalmology Management marks the end of an era — and the start of a new one.
Chief Editor Lisa Feulner, MD, PhD, shares how the publication is evolving to meet the digital age.
🔗 https://ow.ly/4gOf50Xn0fE
#Ophthalmology #EyeCare #DigitalTransformation
👁️ November is Diabetes-Related Eye Disease Month.
Prevent Blindness has launched new bilingual resources and an Eye Health Audio Library to help patients manage diabetes-related vision complications.
Read more: https://ow.ly/Hq7850XkZYi
#DiabetesAwareness #EyeCare
Prevent Blindness has launched new bilingual resources and an Eye Health Audio Library to help patients manage diabetes-related vision complications.
Read more: https://ow.ly/Hq7850XkZYi
#DiabetesAwareness #EyeCare
November 4, 2025 at 4:50 PM
👁️ November is Diabetes-Related Eye Disease Month.
Prevent Blindness has launched new bilingual resources and an Eye Health Audio Library to help patients manage diabetes-related vision complications.
Read more: https://ow.ly/Hq7850XkZYi
#DiabetesAwareness #EyeCare
Prevent Blindness has launched new bilingual resources and an Eye Health Audio Library to help patients manage diabetes-related vision complications.
Read more: https://ow.ly/Hq7850XkZYi
#DiabetesAwareness #EyeCare
👁️ NextGen Healthcare and Eyefinity are joining forces to streamline care for optometrists and ophthalmologists.
Learn how this collaboration could change day-to-day eye care operations:
👉 https://ow.ly/BJZo50XktuE
#Ophthalmology #Optometry #HealthTech #EHR #EyeCare #OphthalmologyManagement
Learn how this collaboration could change day-to-day eye care operations:
👉 https://ow.ly/BJZo50XktuE
#Ophthalmology #Optometry #HealthTech #EHR #EyeCare #OphthalmologyManagement
November 3, 2025 at 2:01 PM
👁️ NextGen Healthcare and Eyefinity are joining forces to streamline care for optometrists and ophthalmologists.
Learn how this collaboration could change day-to-day eye care operations:
👉 https://ow.ly/BJZo50XktuE
#Ophthalmology #Optometry #HealthTech #EHR #EyeCare #OphthalmologyManagement
Learn how this collaboration could change day-to-day eye care operations:
👉 https://ow.ly/BJZo50XktuE
#Ophthalmology #Optometry #HealthTech #EHR #EyeCare #OphthalmologyManagement
We’re heading to OIS! Excited to meet the innovators pushing ophthalmology forward and hear what’s next for the industry.
If you’ll be there too, let’s connect! 👋
#Ophthalmology #Innovation #OISXV #OIS
If you’ll be there too, let’s connect! 👋
#Ophthalmology #Innovation #OISXV #OIS
October 30, 2025 at 2:55 PM
We’re heading to OIS! Excited to meet the innovators pushing ophthalmology forward and hear what’s next for the industry.
If you’ll be there too, let’s connect! 👋
#Ophthalmology #Innovation #OISXV #OIS
If you’ll be there too, let’s connect! 👋
#Ophthalmology #Innovation #OISXV #OIS
Eli Lilly plans to acquire Adverum Biotechnologies in a $1.5B deal for Ixo-vec — a one-time gene therapy that could transform wet AMD treatment.
🔗 https://ow.ly/Tggm50Xj9Bf
#Biotech #Ophthalmology #GeneTherapy
🔗 https://ow.ly/Tggm50Xj9Bf
#Biotech #Ophthalmology #GeneTherapy
October 29, 2025 at 4:50 PM
Eli Lilly plans to acquire Adverum Biotechnologies in a $1.5B deal for Ixo-vec — a one-time gene therapy that could transform wet AMD treatment.
🔗 https://ow.ly/Tggm50Xj9Bf
#Biotech #Ophthalmology #GeneTherapy
🔗 https://ow.ly/Tggm50Xj9Bf
#Biotech #Ophthalmology #GeneTherapy
3-year data are in 👁️
Patients with retinitis pigmentosa treated with MCO-010 maintained 3-line vision gains through 152 weeks — with no serious ocular events.
A one-time, in-office optogenetic therapy showing lasting impact.
Read more 👉 https://ow.ly/71WC50XhrIi
#Ophthalmology
Patients with retinitis pigmentosa treated with MCO-010 maintained 3-line vision gains through 152 weeks — with no serious ocular events.
A one-time, in-office optogenetic therapy showing lasting impact.
Read more 👉 https://ow.ly/71WC50XhrIi
#Ophthalmology
October 28, 2025 at 12:50 PM
3-year data are in 👁️
Patients with retinitis pigmentosa treated with MCO-010 maintained 3-line vision gains through 152 weeks — with no serious ocular events.
A one-time, in-office optogenetic therapy showing lasting impact.
Read more 👉 https://ow.ly/71WC50XhrIi
#Ophthalmology
Patients with retinitis pigmentosa treated with MCO-010 maintained 3-line vision gains through 152 weeks — with no serious ocular events.
A one-time, in-office optogenetic therapy showing lasting impact.
Read more 👉 https://ow.ly/71WC50XhrIi
#Ophthalmology
💧 The next era of #glaucoma care is here.
Drs. Steven Sarkisian and Arkadiy Yadgarov explain how new biointerventional surgery opens both of the eye’s natural outflow pathways — completing the MIGS evolution.
🔗 https://ow.ly/rucg50XcmbE
#Ophthalmology #MIGS #EyeHealth
Drs. Steven Sarkisian and Arkadiy Yadgarov explain how new biointerventional surgery opens both of the eye’s natural outflow pathways — completing the MIGS evolution.
🔗 https://ow.ly/rucg50XcmbE
#Ophthalmology #MIGS #EyeHealth
October 27, 2025 at 2:50 PM
💧 The next era of #glaucoma care is here.
Drs. Steven Sarkisian and Arkadiy Yadgarov explain how new biointerventional surgery opens both of the eye’s natural outflow pathways — completing the MIGS evolution.
🔗 https://ow.ly/rucg50XcmbE
#Ophthalmology #MIGS #EyeHealth
Drs. Steven Sarkisian and Arkadiy Yadgarov explain how new biointerventional surgery opens both of the eye’s natural outflow pathways — completing the MIGS evolution.
🔗 https://ow.ly/rucg50XcmbE
#Ophthalmology #MIGS #EyeHealth
👁️ Everything you need to know in Ophthalmology — all in one place.
From breakthroughs to clinical updates, stay informed with Ophthalmology Management News.
📰 Read the latest: https://ow.ly/qWrV50X8lGg
#EyeCare #VisionResearch #MedicalNews #Ophthalmology
From breakthroughs to clinical updates, stay informed with Ophthalmology Management News.
📰 Read the latest: https://ow.ly/qWrV50X8lGg
#EyeCare #VisionResearch #MedicalNews #Ophthalmology
October 24, 2025 at 12:40 PM
👁️ Everything you need to know in Ophthalmology — all in one place.
From breakthroughs to clinical updates, stay informed with Ophthalmology Management News.
📰 Read the latest: https://ow.ly/qWrV50X8lGg
#EyeCare #VisionResearch #MedicalNews #Ophthalmology
From breakthroughs to clinical updates, stay informed with Ophthalmology Management News.
📰 Read the latest: https://ow.ly/qWrV50X8lGg
#EyeCare #VisionResearch #MedicalNews #Ophthalmology
Does cataract surgery make macular degeneration worse—or could it do the opposite? 👁️
A big data study of 80,000 eyes is challenging decades of assumptions, but researchers say the verdict isn’t final yet.
Here’s what they found 👇
https://ow.ly/pKX250Xg6Lc
#Ophthalmology
A big data study of 80,000 eyes is challenging decades of assumptions, but researchers say the verdict isn’t final yet.
Here’s what they found 👇
https://ow.ly/pKX250Xg6Lc
#Ophthalmology
October 23, 2025 at 2:02 PM
Does cataract surgery make macular degeneration worse—or could it do the opposite? 👁️
A big data study of 80,000 eyes is challenging decades of assumptions, but researchers say the verdict isn’t final yet.
Here’s what they found 👇
https://ow.ly/pKX250Xg6Lc
#Ophthalmology
A big data study of 80,000 eyes is challenging decades of assumptions, but researchers say the verdict isn’t final yet.
Here’s what they found 👇
https://ow.ly/pKX250Xg6Lc
#Ophthalmology